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Background
Activation of tumour-specific T-cells is enhanced dur-
ing homeostatic proliferation of lymphocytes in mice
receiving lymphodepletion, immune reconstitution and
active-specific tumour cell vaccination (LRAST).
Nevertheless, the induction and the therapeutic efficacy
of the tumor-specific T-cells is attenuated by immu-
noregulatory mechanisms such as regulatory T cells
(Treg). Following LRAST, Treg can be derived from
the host or the donor lymphocyte pool. Aim of the fol-
lowing study was to track the origin of the immune
modulating Treg (host vs. donor) and to analyze their
fate following LRAST.
Material and methods
C57BL/6 mice were injected with D5 melanoma cells
(5x104 s.c.) to generate tumour bearing mice. After 3 days
cyclophosphamide (200mg/kg i.p.) was injected to induce
lymphopenia. On day 1 after lymphodepletion, mice were
reconstituted with 2x107 naïve spleen cells from a con-
genic strain of mice (C57BL/6-Ly5.1, 2x107 cells i.v.) and
vaccinated with irradiated, GM-CSF-producing D5G6 cells
(1x107 s.c.). These cells could be distinguished from the
host T-cells based on their leukocyte surface molecule
(host leukocytes: CD45.2+, donor leukocytes: CD45.1+).
Mice without lymphodepletion served as a control. On
day 3, 10 and 23 after lymphodepletion, cell populations
were phenotypically analyzed by flow cytometry of spleno-
cytes and blood cells. CD3+CD4+CD25+Foxp3+ cells were
considered Treg; tumour specificity was controlled by
IFN-g cytokine release assays.
Results
In the lymphodepleted mice, flow cytometric analysis of
splenocytes showed a decline in the host Treg between
day 3 and day 10, followed by a recovery of the cells
until day 23. In mice without lymphodepletion, host
Treg remained at a constant level throughout the
experiment. In contrast to that, we observed a steady
increase over time in reconstituted Treg with a 5- to
8-fold increase from day 3 to day 23 in both lymphode-
pleted and not lymphodepleted mice. In LRAST-treated
mice we were able to induce a higher frequency of
tumour-specific T-cells compared to not lymphode-
pleted mice, as observed by tumor-specific cytokine
release assays.
Conclusion
Due to the proliferation of transferred Treg and increased
levels of host Treg after lymphodepletion until day 23, the
induction of tumor-specific T-cells might be limited. In
future experiments we will determine whether the selec-
tive reduction of transferred Treg or the depletion of Treg
with a specific anti-CD25 monoclonal antibody in the host
will improve the induction of tumour-specific T cells and
the therapeutic efficacy of active-specific tumour vaccina-
tion following LRAST.
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